Uss Investment Management LTD Novo Cure LTD Transaction History

Uss Investment Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $74,485 - $118,308	-1,316 Reduced 15.99%	6,912 $481,000
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $729,499 - $1.03 Million	-12,128 Reduced 59.58%	8,228 $682,000
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $2.36 Million - $3.96 Million	20,356 New	20,356 $2.36 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Uss Investment Management LTD with notifications on news.